arginyl-glycyl-aspartic acid has been researched along with Cancer of the Thyroid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sood, A; Vatsa, R | 1 |
| Bhusari, P; Kumar, R; Mittal, BR; Parihar, AS; Shukla, J; Sood, A | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and Cancer of the Thyroid
| Article | Year |
|---|---|
Theranostic role of radiolabelled RGD peptide in the treatment of radioiodine-resistant thyroid cancer: A novel agent.
Topics: Humans; Iodine Radioisotopes; Oligopeptides; Precision Medicine; Thyroid Neoplasms | 2020 |
Novel use of
Topics: Carcinoma, Papillary; Female; Heterocyclic Compounds, 1-Ring; Humans; Iodine Radioisotopes; Lutetium; Middle Aged; Oligopeptides; Radioisotopes; Radionuclide Imaging; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |